Xiao, a professor spanning the fields of chemistry, bioengineering, and biosciences, serves as the director of Rice Synthesis X (SynthX), an innovative center uniting chemical biology, nanomaterial synthesis, and organic chemistry to accelerate therapeutic development. His research trajectory focuses on the design and development of chemical tools that interrogate and manipulate biological systems with precision, aiming to translate these discoveries into clinically relevant therapies. Xiao’s team works at the intersection of synthetic chemistry and biology to create molecular entities capable of guiding therapeutic action with specificity and efficiency.

Central to Xiao’s scientific endeavors is his pioneering approach to cancer therapy. By integrating principles from synthetic chemistry, molecular biology, and immunology, he has engineered therapeutic strategies that target tumor microenvironments and metastatic niches. Notably, his research team has introduced a bone-targeting antibody therapy that represents a paradigm-shifting approach, enabling the delivery of biologics specifically to bone tumors and metastases. This innovative concept of skeleton-targeted therapeutics has broad implications for metastatic cancers, notably breast and prostate cancer, where bone metastasis significantly worsens prognosis.

In addition to this breakthrough, Xiao uncovered a novel glyco-immune checkpoint within the bone metastatic niche. This discovery revealed a mechanism by which tumor cells exploit glycosylation patterns to create an immunosuppressive milieu, thereby evading immune-mediated destruction. By targeting and blocking this checkpoint, Xiao’s research demonstrates the ability to reprogram the tumor microenvironment, restoring immunotherapy sensitivity and improving therapeutic outcomes. This work has provided new insights into immune regulation within metastatic cancer and has shaped the development of next-generation immunomodulatory therapies.

The translational impact of Xiao’s work is further evidenced by the founding of OsteoLogic Therapeutics in 2022, a venture dedicated to advancing skeleton-targeted drug delivery systems. Supported by forward-thinking venture entities such as Curie.Bio, Pillar VC, and New York Ventures, OsteoLogic is actively developing therapies that selectively target bone metastases from breast and prostate cancers, aiming to mitigate disease progression and enhance patient quality of life. The company’s platform leverages the molecular principles elucidated in Xiao’s research, emphasizing targeted delivery and immune modulation.

SynthX, under Xiao’s leadership, harnesses multidisciplinary collaborations spanning chemical biology, nanotechnology, and cancer immunology to drive innovative therapeutic solutions. The center has cultivated significant partnerships with top-tier institutions in the Texas Medical Center, including Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center, Houston Methodist, and the University of Texas MD Anderson Cancer Center. These alliances foster a vibrant ecosystem for translational research, accelerating the bench-to-bedside pipeline for novel cancer therapeutics.

Xiao’s laboratory focuses on developing novel molecular building blocks that enhance the functional specificity and efficacy of chemical-biological tools. Through sophisticated synthetic methodologies, his team delivers molecules capable of modifying cellular pathways with unprecedented precision. These innovations allow for the modulation of pathogenic processes underlying cancer, autoimmunity, and metabolic diseases. His research strategy integrates glycobiology and cancer immunology, fields that illuminate the complex interactions governing disease progression and therapeutic response.

The scientific community has recognized Xiao’s integrated approach to merging fundamental chemistry with biological complexity as transformative. His ability to engineer molecules that serve both as probes and therapeutic agents exemplifies the power of chemical biology in solving intricate biomedical challenges. The tools developed in his lab not only elucidate cellular mechanisms but also serve as blueprints for designing next-generation medicines.

Central to Xiao’s vision is the concept of leveraging synthetic chemistry to engineer smarter, more targeted therapeutics that minimize off-target effects and improve patient outcomes. His team employs cutting-edge synthetic techniques to generate molecular entities with tailored functionalities that can navigate the sophisticated landscapes of tumor microenvironments. This strategy enhances drug efficacy while reducing undesirable systemic toxicity, a perennial challenge in cancer therapy.

The discovery of the glyco-immune checkpoint is illuminating new modalities in immunotherapy, showcasing how carbohydrate-mediated interactions within the tumor niche can regulate immune cell activity. By unraveling these complex biochemical pathways, Xiao’s work is pioneering novel checkpoint blockade strategies that complement and potentially overcome resistance to existing immunotherapies, heralding a new chapter in cancer modulation.

Xiao’s innovative approach extends beyond cancer to encompass autoimmune and metabolic disorders, deploying his chemical biology expertise to modulate cellular behavior in diverse pathological contexts. His translational research is rooted in understanding how chemical agents can be harnessed to restore normal cellular function or selectively eliminate diseased cells, broadening the impact of his work across multiple domains of medicine.

In conclusion, Han Xiao’s award acknowledges his leadership in medicinal chemistry and chemical biology, exemplified by his pioneering development of bone-targeted biologics and glyco-immune checkpoint inhibitors. His work epitomizes the synthesis of chemical innovation with biomedical application, driving forward the frontiers of therapeutic discovery with the promise of more precise and effective treatments across oncology and beyond.

Subject of Research: Medicinal chemistry and translational chemical biology focused on cancer therapeutics and immune modulation

Article Title: Rice’s Han Xiao Honored with David W. Robertson Award for Excellence in Medicinal Chemistry

News Publication Date: Not explicitly provided; award ceremony scheduled for March 24, 2026

Web References:

• https://profiles.rice.edu/faculty/han-xiao
• https://synthx.rice.edu/
• https://news.rice.edu/news/2021/drug-doubles-down-bone-cancer-metastasis
• https://news.rice.edu/news/2024/rice-study-unlocks-breakthrough-breast-cancer-bone-metastases

Image Credits: Courtesy of Rice University

Keywords: Medicinal chemistry, chemical biology, cancer therapy, bone metastasis, glyco-immune checkpoint, synthetic chemistry, immunotherapy, molecular biology, bioengineering, translational research, cancer immunology, bone-targeted biologics

The conference’s theme, “Chemistry Powering Multidisciplinary Solutions,” was exemplified through the sheer breadth and depth of presentations offered. Attendees engaged with a rich mosaic of topics spanning energy materials, chemical biology, environmental science, sustainable technologies, and novel materials design. Over 10,000 talks, posters, and interactive sessions illuminated recent breakthroughs, such as advancements in hydrogen production efficiency via catalytic optimization and pioneering approaches in the clinical application of targeted protein degradation, indicating the field’s dynamic interconnection with health sciences and renewable energy.

The exhibition hall emerged as a vibrant nexus for scholarly exchange, where leading academic publishers displayed comprehensive suites of specialized journals. Maximum Academic Press notably drew significant attention by promoting its portfolio titled the NEW Community of Journals. This collective of ten highly curated scientific journals embodies a commitment to fostering interdisciplinary research and sustainable development. The publisher’s booths facilitated direct engagement between attendees and editorial teams, providing invaluable insights into manuscript submission processes, open access policies, and emergent scientific trends driving contemporary research landscapes.

Within this constellation of journals, the NEW Community has swiftly established itself as an influential presence. It encompasses established SCIE-indexed journals such as Biochar and Ei Compendex-indexed journals like Carbon Research, supplemented by a growing number of newly launched titles targeting crucial niches within environmental sciences, materials science, and energy studies. This diversified collection reflects a strategic alignment with contemporary global imperatives, including ecological conservation, renewable energy, and pollution mitigation.

Biochar, with an impact factor of 13.5, exemplifies the interdisciplinary appeal of these journals. Published by Springer Nature, it addresses the synthesis, characterization, and application of biochar materials in agriculture, environmental remediation, and climate change mitigation. Its research scope extends to rural development and sustainable agriculture, emphasizing biochar’s multifaceted capabilities in soil enhancement, carbon sequestration, and pollutant adsorption. The journal’s growing influence is a testament to the rising importance of biochar technologies as tools for ecological resilience.

Similarly, Carbon Research has gained notable prominence, boasting a CiteScoreTracker of 16.1 in 2025. Its interdisciplinary coverage spans advanced carbon materials, energy storage technologies, and environmental applications, positioning it at the forefront of materials science and sustainable energy research. The journal’s content underscores the critical role carbon-based materials play not only in traditional sectors like electronics and catalysis but also in emergent areas such as flexible energy devices and environmental sensors.

The newer additions to the NEW Community portfolio further broaden its scientific horizon. Titles such as Agricultural Ecology and Environment delve into the intricate interactions within agroecosystems and their environmental contexts, fostering research that bridges ecology, agriculture, and sustainability. Biochar X pushes the boundaries of biochar research by exploring novel applications and engineering advances. Other journals, including Biocontaminant and New Contaminants, focus on biological and chemical pollutants, addressing emerging challenges in environmental safety and public health. Energy & Environment Nexus interweaves energy issues with ecological impacts, while journals like Environmental and Biogeochemical Processes and Nitrogen Cycling deepen our understanding of elemental cycles crucial for ecosystem functioning. Sustainable Carbon Materials addresses the creation and utilization of carbon-based materials with a lens on environmental compatibility and performance.

The conference illuminated how the synergy between these journals and the broader research community fosters a more integrated approach to chemical and environmental sciences. Presentations and discussions emphasized the importance of translating molecular-level innovations into scalable, real-world solutions. For instance, sessions on hydrogen production delved into catalytic mechanisms and reactor designs that optimize energy efficiency and reduce emissions, showcasing how fundamental chemistry underpins critical technological progress. The clinical advances in targeted protein degradation highlighted translational bioorganic chemistry’s capacity to revolutionize therapeutic modalities.

For many scientists, particularly early-career researchers, ACS Fall 2025 offered a rare opportunity to gain international visibility and establish collaborative networks. The platform allowed researchers to present findings, solicit peer feedback, and exchange ideas across disciplinary boundaries. This dynamic environment supports the cross-fertilization of concepts, accelerating innovations addressing global challenges like climate change, energy security, and sustainable agriculture. The conference reinforced the role of chemistry as a linchpin science that integrates perspectives from biology, physics, engineering, and environmental sciences.

The presence of leading journals such as Biochar and Carbon Research, alongside emergent titles, at the ACS meeting attests to the evolving landscape of scientific publishing. These publications serve as vital conduits for disseminating high-impact research, enabling rapid communication and fostering open scientific dialogue. Their editorial focus on sustainability and interdisciplinarity aligns with the global scientific community’s urgent need to address complex environmental and technological issues through integrated knowledge.

Looking forward, the implications of ACS Fall 2025 extend beyond the immediate event. The connections forged and insights gained are catalysts for ongoing research endeavors and collaborative initiatives. The conferences and forums hosted under the ACS umbrella continue to inspire innovative research agendas that harness chemistry’s power to develop novel materials, energy solutions, and environmental interventions. The NEW Community of Journals, by amplifying such research, is positioned to influence policy, technology development, and educational frameworks at global scales.

The success of ACS Fall 2025 underscores a pivotal moment in scientific history, where multidisciplinary approaches and sustainable development principles converge to shape the future of chemical sciences. As attendees return to their respective institutions, the momentum generated promises to fuel further discoveries and strengthen the integration of chemistry within the wider scientific and societal milieu. The role of premier journals in this ecosystem, particularly those championing ecological stewardship and innovation, will be paramount in guiding research priorities and disseminating groundbreaking knowledge.

In summary, the ACS Fall 2025 meeting in Washington, DC, was a powerful demonstration of chemistry’s centrality to global scientific advancement and problem-solving. The showcase of the NEW Community of Journals highlighted how scholarly communication evolves hand in hand with research frontiers, ensuring that transformative ideas in biochar science, carbon materials, environmental processes, and energy systems reach wide audiences. The enduring impact of this gathering will be measured not only by the immediate dialogues but by the sustained progress in tackling the critical challenges of the 21st century through chemical innovation.

Subject of Research: Chemistry and Multidisciplinary Applications in Sustainable Development

News Publication Date: August 2025

Web References:

• Biochar: https://link.springer.com/journal/42773
• Carbon Research: https://link.springer.com/journal/44246
• Agricultural Ecology and Environment: https://www.maxapress.com/aee
• Biochar X: https://www.maxapress.com/bchax
• Biocontaminant: https://www.maxapress.com/biocontam
• Energy & Environment Nexus: https://www.maxapress.com/een
• Environmental and Biogeochemical Processes: https://www.maxapress.com/ebp
• New Contaminants: https://www.maxapress.com/newcontam
• Nitrogen Cycling: https://www.maxapress.com/nc
• Sustainable Carbon Materials: https://www.maxapress.com/scm

Image Credits: Biochar Editorial Office, courtesy of the NEW Community of Journals display at ACS Fall 2025

Keywords: Carbon, Agricultural Engineering, Environmental Sciences, Materials Science, Sustainable Agriculture, Climate Change, Energy Storage